Literature DB >> 15677803

Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride.

Eberhard Standl1, Stephan Maxeiner, Sotirios Raptis, Zahra Karimi-Anderesi, Matthias Axel Schweitzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15677803     DOI： 10.2337/diacare.28.2.419

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.

Authors:  Boris Kovatchev; Guillermo Umpierrez; Andres DiGenio; Rong Zhou; Silvio E Inzucchi
Journal:  J Diabetes Sci Technol       Date:  2015-06-15

Review 2.  Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.

Authors:  Sanjay Kalra; Silver Bahendeka; Rakesh Sahay; Sujoy Ghosh; Fariduddin Md; Abbas Orabi; Kaushik Ramaiya; Sameer Al Shammari; Dina Shrestha; Khalid Shaikh; Sachitha Abhayaratna; Pradeep K Shrestha; Aravinthan Mahalingam; Mazen Askheta; Aly Ahmed A Rahim; Fatimah Eliana; Hari K Shrestha; Sandeep Chaudhary; Nancy Ngugi; Jean Claude Mbanya; Than Than Aye; Tint Swe Latt; Zhanay A Akanov; Abbas Raza Syed; Nikhil Tandon; A G Unnikrishnan; S V Madhu; Ali Jawa; Subhankar Chowdhury; Sarita Bajaj; Ashok Kumar Das
Journal:  Indian J Endocrinol Metab       Date:  2018 Jan-Feb

3.  Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.

Authors:  Lawrence Blonde; Stephen A Brunton; Pavan Chava; Rong Zhou; Juliana Meyers; Keith L Davis; Mehul R Dalal; Andres DiGenio
Journal:  Diabetes Spectr       Date:  2019-05

4.  Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy.

Authors:  Udaya M Kabadi
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04

5.  How much is too much? Outcomes in patients using high-dose insulin glargine.

Authors:  T Reid; L Gao; J Gill; A Stuhr; L Traylor; A Vlajnic; A Rhinehart
Journal:  Int J Clin Pract       Date:  2015-11-13       Impact factor: 2.503

6.  BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin.

Authors:  Ariel Zisman; Francienid Morales; John Stewart; Andreas Stuhr; Aleksandra Vlajnic; Rong Zhou
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.